Arhgef15 promotes retinal angiogenesis by mediating VEGF-induced Cdc42 activation and potentiating RhoJ inactivation in endothelial cells.
BACKGROUND: Drugs inhibiting vascular endothelial growth factor (VEGF) signaling are globally administered to suppress deregulated angiogenesis in a variety of eye diseases. However, anti-VEGF therapy potentially affects the normal functions of retinal neurons and glias which constitutively express...
Main Authors: | Sentaro Kusuhara, Yoko Fukushima, Shigetomo Fukuhara, Lars Martin Jakt, Mitsuhiro Okada, Yuri Shimizu, Masayuki Hata, Kohji Nishida, Akira Negi, Masanori Hirashima, Naoki Mochizuki, Shin-Ichi Nishikawa, Akiyoshi Uemura |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3448698?pdf=render |
Similar Items
-
Oncogenic Gαq activates RhoJ through PDZ-RhoGEF
by: Rodolfo Daniel Cervantes-Villagrana, et al.
Published: (2023-10-01) -
Towards Understanding the Development of Breast Cancer: The Role of RhoJ in the Obesity Microenvironment
by: Lara J. Bou Malhab, et al.
Published: (2024-01-01) -
The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomas.
by: Rolando Ruiz, et al.
Published: (2017-07-01) -
Rho GTPase activity crosstalk mediated by Arhgef11 and Arhgef12 coordinates cell protrusion-retraction cycles
by: Suchet Nanda, et al.
Published: (2023-12-01) -
Rho GTPases in Retinal Vascular Diseases
by: Akiyoshi Uemura, et al.
Published: (2021-04-01)